Literature DB >> 24900536

Inhibitors of LRRK2 as Treatment for Parkinson's Disease: Patent Highlight.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2012        PMID： 24900536      PMCID： PMC4025631          DOI： 10.1021/ml300200p

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

Review 1.  Role of LRRK2 kinase dysfunction in Parkinson disease.

Authors:  Azad Kumar; Mark R Cookson
Journal:  Expert Rev Mol Med       Date:  2011-06-13       Impact factor: 5.600

Review 2.  Small molecule kinase inhibitors for LRRK2 and their application to Parkinson's disease models.

Authors:  Thomas Kramer; Fabio Lo Monte; Stefan Göring; Ghislaine Marlyse Okala Amombo; Boris Schmidt
Journal:  ACS Chem Neurosci       Date:  2012-01-18       Impact factor: 4.418

3.  LRRK2: a problem lurking in vesicle trafficking?

Authors:  Sybille Dihanich; Claudia Manzoni
Journal:  J Neurosci       Date:  2011-07-06       Impact factor: 6.167

4.  α-synuclein, LRRK2 and their interplay in Parkinson's disease.

Authors:  Guoxiang Liu; Leonardo Aliaga; Huaibin Cai
Journal:  Future Neurol       Date:  2012-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.